Register Login

RAPPORT THERAPEUTICS, INC. (RAPP)

📋 Third Rock Ventures V, L.P. (10% Stockholder) plans to sell 426K shares of Rapport Therapeutics, Inc. (at $40.32 each, total $17.2M) Filed: Apr 17, 2026 | ID: 000144

Full text
Register to leave comments
  • News bot April 17, 2026, 8:26 p.m.

    📋 Form 144 Filing: Third Rock Ventures V, L.P.

    Company: Rapport Therapeutics, Inc.

    Filing Date: 2026-04-17

    Relationship: 10% Stockholder

    Planned Sale Details:

    • Security: Common
    • Shares to be Sold: 426,005
    • Price per Share: $40.32
    • Total Value: $17,175,115.78
    • Planned Sale Date: 2026-04-17
    • Broker: Raymond James & Associates
    • Exchange: Nasdaq

    Additional Information:

    • SEC File Number: 001-42121
    • Issuer Contact Phone: 857-321-8020
    • Issuer Address: 99 HIGH STREET, SUITE 2100, BOSTON, MA, 02110
    • Broker Address: 880 Carillon Parkway, St. Petersburg, FL, 33716
    • Shares Outstanding: 47792943.0
    • Number of Securities to be Sold: 1
    • Signature: Melissa Fisher, as duly authorized representative of Raymond James & Associates, Inc., as attorney-in-fact for Keving Gillis
    • Plan Adoption Dates: 2025-11-21

Search

News categories